Sort
78,016 grants matching “breast cancer”
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St
$1,238,550Michael Clarke · Stanford University · U54 · FY2007 · CA
3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Partnership
$1,237,451Upender Manne · University Of Alabama At Birmingham · U54 · FY2025 · CA
Indiana University Melvin and Bren Simon Cancer Center Support Grant
$1,237,416Patrick J Loehrer · Indiana University Indianapolis · P30 · FY2012 · CA
A turnkey research platform to accelerate clinical translation of targeted immune-modulation enhanced therapies
$1,237,360Ryan Gessner · Sonovol, Inc. · R44 · FY2021 · CA
Novel SCD1 inhibitors for treatment of cancer
$1,236,819John A Copland · Modulation Therapeutics, Inc. · R42 · FY2019 · CA
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2
$1,236,673Jean Wactawski-Wende · State University Of New York At Buffalo · N01 · FY2025 · HL
Signaling events regulating chemotaxis
$1,236,641Carole Parent · Basic Sciences · Z01 · FY2007 · CA
GENETIC EPIDEMIOLOGY OF LUNG CANCER
$1,236,518University Of Cincinnati · U01 · FY2003 · CA
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$1,236,331Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Deep South Network for Cancer Control
$1,236,050Edward E Partridge · University Of Alabama At Birmingham · U54 · FY2011 · CA
Surgery Branch Cell Prep Core
$1,236,025John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Cell Production Core Facility
$1,236,025Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
TARGETING CHROMATIN REGULATOR WDR5 TO TREAT BREAST CANCER METASTASIS
$1,235,447Yale Univ · · FY2025 · Defense Health Agency
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
$1,234,720Michelle A T Hildebrandt · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
Deep South Network for Cancer Control
$1,234,642Edward E Partridge · University Of Alabama At Birmingham · U54 · FY2012 · CA
COTARGETING THE TUMOR MICROENVIRONMENT TO REVOLUTIONIZE ANTIBODY-DRUG CONJUGATE THERAPY FOR REFRACTORY BREAST CANCERS
$1,234,505The General Hospital Corporation · · FY2025 · Defense Health Agency
Recruitment and Data Collection
$1,234,464Unhee Lim · University Of Hawaii At Manoa · P01 · FY2013 · CA
Center for Advanced Magnetic Resonance Technology at Stanford
$1,233,349Gary H Glover · Stanford University · P41 · FY2010 · RR
EXTENDING THE SURVIVAL OF HR+ BREAST CANCER PATIENTS RECEIVING CDK4/6 INHIBITORS BY TARGETING IL 17-PRODUCING GAMMA DELTA T CELLS
$1,233,118Weill Medical College Of Cornell University · · FY2022 · Defense Health Agency
INHIBITING INTERACTION OF PNUTS WITH THE MYC FAMILY OF ONCOPROTEINS TO EFFECTIVELY TARGET BREAST CANCER
$1,232,483University Health Network · · FY2021 · Defense Health Agency
Surveillance Epidemiology and End Results (SEER) Program - Hawaii
$1,232,092Marc T Goodman · University Of Hawaii At Manoa · N01 · FY2009 · CA
TRANSLATIONAL BREAST CANCER RESEARCH: A MENTOR/PROTEGE COLLABORATIVE BETWEEN ALBANY STATE UNIVERSITY AND MEDICAL COLLEGE OF GEORGIA
$1,232,015Albany State University · · FY2010 · Department of Defense
Replication of Human Endogenous Retroviruses in Modern Humans
$1,231,806David Michael Markovitz · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
TEXAS CANCER GENETICS CONSORTIUM
$1,231,684University Of Texas Md Anderson Can Ctr · U24 · FY2001 · CA
Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells
$1,231,679Esta Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA